Abstract
Most cardiovascular functions exhibit circadian changes. On one hand, predictable-in-time differences in the physiological status of the cardiovascular system give rise to rhythmic variations in the susceptibility to morbid and mortal events. On the other, the pathological mechanisms of cardiovascular disease exhibit temporal changes in both their manifestation and severity, leading to predictable-in-time differences in the ability to precipitate the overt expression of disease. It is known that the occurrence of cardiovascular events shows temporal patterns that vary with time. The incidence of potentially life-threatening cardiovascular events, e.g. acute myocardial ischemia and infarction, sudden cardiac death, ischemic and hemorrhagic stroke, and rupture or dissection of aortic aneurysms, displays a diurnal pattern, tending to be higher in the morning. On arousal and the start of daily activities, blood pressure (BP) shows a surge that may last 4- 6 h. Morning BP surge, together with circadian variations in biochemical and physiological parameters, may be potential triggers for acute cardiovascular events. This may open up potential for applications in medical therapy. It is possible that antihypertensive medication given once daily in the morning may not protect against this surge if its duration of action is too short. Thus, the timing of drug administration or specific drug delivery systems that lead to a greater effect at night and/or mitigate the early morning BP surge may provide protection against cardiovascular events.
Keywords: Blood pressure, morning blood pressure surge, chronobiology, circadian rhythm, myocardial infarction, stroke, pulmonary embolism, aneurysm dissection, risk factors, cardiovascular diseases
Related Journals
Related eBooks
Related Articles
-
miR-29c-3p is an Effective Biomarker of Abdominal Aortic Aneurysm in Patients Undergoing Elective Surgery
MicroRNA The Coronary Collateral Circulation in Man
Current Cardiology Reviews Renal Function Impairment in Patients Undergoing Elective EVAR vs. Elective Open Repair During Follow up Period: A Systematic Review of the Literature
Current Vascular Pharmacology Chymase as an Important Target for Preventing Complications of Metabolic Syndrome
Current Medicinal Chemistry Dissecting abdominal aortic aneurysm in Angiotensin II-infused mice: the importance of imaging
Current Pharmaceutical Design Anaerobic Bacteria as a Cause of Mycotic Aneurysm of the Aorta: Microbiology and Antimicrobial Therapy
Current Cardiology Reviews Gauzoma in A Scleroderma Patient Following Open Heart Surgery: A Case Report
Current Rheumatology Reviews Developments in Non-Surgical Therapies for Abdominal Aortic Aneurysm
Current Vascular Pharmacology Patent Foramen Ovale in Cerebral Infarction
Current Cardiology Reviews Pathogenic and Therapeutic Significance of Angiotensin II Type I Receptor in Abdominal Aortic Aneurysms
Current Drug Targets Smoking and Atherosclerosis: Mechanisms of Disease and New Therapeutic Approaches
Current Medicinal Chemistry Inflammatory Mechanisms in Atherosclerosis: The Impact of Matrix Metalloproteinases
Current Topics in Medicinal Chemistry Ruptured Multiple Mycotic Aneurysms Following Infective Endocarditis: Effectiveness of Catheter-based Techniques Using N-butyl Cyanoacrylate in a Hemorrhage-induced Coagulopathy
Current Medical Imaging Development of Nucleic Acid Drugs for Neurological Disorders
Current Topics in Medicinal Chemistry Analysis of Nitric Oxide (NO) in Cerebral Vasospasm After Aneursymal Bleeding
Reviews on Recent Clinical Trials Transforming Growth Factor β Signaling Perturbation in the Loeys-Dietz Syndrome
Current Medicinal Chemistry The Role of Endothelial Dysfunction in Aortic Aneurysms
Current Pharmaceutical Design Automated Computerized Method for the Detection of Unruptured Cerebral Aneurysms in DSA Images
Current Medical Imaging Molecular Genetics of Abdominal Aortic Aneurysm: Therapeutic Implications
Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics) The Rationale for Comparative Studies of Accelerated Atherosclerosis in Rheumatic Diseases
Current Vascular Pharmacology